InsiderTrades

Form 4 for CLB Core Laboratories Inc. /DE/

Accepted 2023-05-02 00:00:00 ET · period of report 2023-05-01 · accession 0001209191-23-026793 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-05-02 2023-05-01 CLB Tattoli Mark Damian SVP, Gen Counsel, Sec M - OptEx $0.00 +450 5,366 +9% $0
DM 2023-05-02 2023-05-01 CLB Tattoli Mark Damian SVP, Gen Counsel, Sec F - Tax $22.03 -174 5,289 -3% -$3,833
DM 2023-05-02 2023-05-01 CLB Tattoli Mark Damian SVP, Gen Counsel, Sec M - OptEx $0.00 -450 5,850 -7% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-05-01 M A 250 $0.00 5,538.62 D — —
2 Common Common Stock 2023-05-01 M A 200 $0.00 5,365.62 D — —
3 Common Common Stock 2023-05-01 F D 97 $22.03 5,441.62 D — —
4 Common Common Stock 2023-05-01 F D 77 $22.03 5,288.62 D — —
5 Derivative Restricted Shares 2023-05-01 M D 250 $0.00 5,600 D — · — to — 250 Common Stock (F2) Mulitple restricted share grants are included in this total. (F1) The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date
6 Derivative Restricted Shares 2023-05-01 M D 200 $0.00 5,850 D — · — to — 200 Common Stock (F2) Mulitple restricted share grants are included in this total. (F1) The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date